Virtu Financial’s Applied Therapeutics APLT Stock Holding History

Virtu Financial’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-496,288	Closed	-$50K	–	1606
2025 Q4	$50K	Buy	496,288 +445,271	+873%	+$283K	﹤0.01%	1302
2025 Q3	$31K	Buy	+51,017	New	+$24K	﹤0.01%	1219
2025 Q1	–	Sell	-21,414	Closed	-$18K	–	1327
2024 Q4	$18K	Buy	+21,414	New	+$134K	﹤0.01%	1313
2023 Q2	–	Sell	-14,497	Closed	-$12K	–	1486
2023 Q1	$12K	Buy	+14,497	New	+$14.3K	﹤0.01%	1324

Virtu Financial's APLT Position: Q1 2026 in Review

Virtu Financial sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 496,288 shares — an estimated $50K sold.

Virtu Financial first reported a position in APLT in Q1 2023 and held it in 4 quarters. The position peaked at $50K in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Virtu Financial reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 496,288 Applied Therapeutics shares in Q1 2026, an estimated $50K.
Virtu Financial first reported a position in Applied Therapeutics in Q1 2023 and held it in 4 quarters.
Virtu Financial's Applied Therapeutics position peaked at $50K in Q4 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.